NEW YORK and MISSISSAUGA, Ontario, July 11, 2011 /PRNewswire/ —
CardioGenics Holdings Inc. (CGNH.OB) announced today that Dr. Yahia
Gawad, MB, Ch.B., MD, MSc., Director and CEO of CardioGenics, will
be presenting at RetailInvestorConferences.com.DATE: July 12,
2011TIME: 2:00 PM EDTLINK:www.retailinvestorconferences.comThis
will be a live, interactive online event where investors are
invited to ask the company questions in real-time, both in the
presentation hall as well as the company’s “virtual trade booth.”
If attendees are not able to join the event live in real-time an
on-demand archive will be available for 90 days.

It is recommended that investors
pre-register to save time and receive event updates.

About CardioGenics Holdings Inc.Through its operating
subsidiaries, the Company develops ultra-sensitive analyzers and
other products targeting the immunoassay segment of the
Point-Of-Care IVD testing market. It has developed the QL
Care™ Analyzer, a proprietary and ultra-sensitive
Point-Of-Care immuno-analyzer, which will run a number of
diagnostic tests under development, the first of which will be a
series of cardiovascular diagnostic tests. As part of its core
proprietary technology, the Company has also developed a
proprietary method for silver coating paramagnetic microspheres (a
fundamental platform component of immunoassay equipment), which
improve instrument sensitivity to light. The Company’s proprietary
microspheres technology and SAVAsphere™ magnetic beads are
developed and marketed through the Company’s Luxspheres subsidiary.
 The Company’s principal offices are located in Mississauga,
Ontario, Canada.  For more information please visit www.cardiogenics.com and

SOURCE